Posterior capsulotomy: history of using the YAG laser and best practices Alanna Nattis, DO SightMD Babylon, New York Robert Weinstock, MD The Eye Institute of West Florida Largo, Florida Stephen Weinstock, MD The Eye Institute of West Florida Largo, Florida JULY 2023 | EYEWORLD Following cataract surgery, patients may experience blurry vision. A posterior capsulotomy with the YAG laser is often employed by physicians as a solution to help patients achieve their desired vision. “A YAG capsulotomy has to be one of the most commonly performed procedures for a cataract and refractive surgeon,” said Robert Weinstock, MD. “Fortunately, it’s a safe, easy, and efficient technology.” Prior to YAG capsulotomies and the invention of the YAG laser, this was a much more challenging condition because it required going back into the eye and doing a surgical procedure, with the risk of infection. In addition,...
Using CTRs in practice Cataract: Complicated cases September 2023 EYEWORLD by Ellen Stodola Editorial Co-Director A capsular tension ring (CTR) can be a useful tool for ophthalmologists to have on hand during surgery. Two physicians discussed the available products, when the best time is to use them, and methods for good placement. John Hart Jr., MD, said there are three CTR products that he routinely uses: a standard CTR, a Cionni CTR, and the Ahmed capsular tension segment. “I use a CTR in approximately 10% of my cataract cases,” Dr. Hart said. “Patients with zonular abnormalities are commonly referred to me by other ophthalmologists. I think that most ophthalmologists don’t use them as frequently as I do.” When a CTR is properly positioned in the capsular bag, it distributes support from areas with intact zonules to areas with weak or missing zonules, Dr. Hart said. The CTR also keeps the equator of the capsular bag expanded in areas where zonules are missing. “This is i...
Pharmaceutical focus The next wave of novel dry eye therapies -------------------------------------------------------------------------------- by Maxine Lipner Senior EyeWorld Contributing Editor Novel therapies are in development they may help patients with dry eye (pictured here) Source: Alan N. Carlson, M.D. New agents poised for takeoff Let's face it: Dry eye is everywhere, with many patients suffering from this all- too-common condition. EyeWorld looked at some novel therapies working their way through the pipeline that could help bring additional relief to some of these dry eye sufferers. New T-cell modulator Mention T-cell modulator to practitioners and Restasis (cyclosporine, Allergan, Irvine, Calif.) immediately comes to mind. Now a new T-cell modulator, SAR 1118 (lifitegrast, SARcode Bioscience, Brisbane, Calif.), is winding its way through channels. Eric D. Donnenfeld, M.D., co-chairman, Cornea, Nassau University Medical Center, East Mead...
留言
張貼留言